Yili Chuanning Biotechnology Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Yili Chuanning Biotechnology Co., Ltd. (hereinafter referred to as "Chuanning Biotechnology") is a subsidiary invested by Sichuan Kelun Pharmaceutical Co., Ltd. (hereinafter referred to as "Kelun Pharmaceutical") in Yining Industrial Park, Khorgos Economic Development Zone, Xinjiang in December 2010. The Khorgos Economic Development Zone is the core area of the Silk Road Economic Belt under the national "the Belt and Road" development strategy, Mainly engaged in the research and industrialization of biological fermentation technology. The project covers an area of 1319 acres and has a total investment of over 8 billion yuan. It has constructed one production line for erythromycin thiocyanate, two production lines for cephalosporin series intermediates, and one production line for crude ursodeoxycholic acid, with a total production capacity of approximately 16000 tons/year. The main products include erythromycin thiocyanate, cephalosporin intermediates (7-ACA, 7-ADCA, D-7ACA), penicillin intermediates (6-APA, penicillin G potassium salt), and crude ursodeoxycholic acid, It is one of the largest domestic and global suppliers of antibiotic intermediates. At present, Chuanning Biotechnology has about 2800 employees, including over 2100 employees from Xinjiang, over 1800 local employees from Ili, and about 1000 ethnic employees, covering 20 ethnic groups such as Uyghur, Kazakh, Kirgiz, Uzbek, Dongxiang, Xibe, Manchu, Mongolian, and Hui, with ethnic minority employees accounting for over 30%. It has been successively rated as a "Model Collective for National Unity and Progress" and a "Micro Action Loving Unit for Maintaining Social Stability". In 2019, Chuanning Biotechnology achieved a total industrial output value of 3.273 billion yuan, accounting for 36.78% of the total industrial output value of enterprises above designated size in Yining City; Realized a profit and tax revenue of 178 million yuan, accounting for 8.77% of the tax revenue of Yining City. In 2020, Chuanning Biotechnology achieved a total industrial output value of 3.389 billion yuan, accounting for 29.60% of the total output value of enterprises above designated size in Yining City; Realized a profit and tax revenue of 468 million yuan, accounting for 22.50% of the tax revenue of Yining City. In 2021, the total industrial output value was 2.875 billion yuan, accounting for 18.29% of the total output value of enterprises above designated size in Yining City; Realized a profit and tax revenue of 257 million yuan, accounting for 10.89% of the tax revenue of Yining City. Chuanning Biotechnology has always adhered to the strategy of "prioritizing environmental protection and sustainable development", and has always adhered to the concept of "establishing a global environmental model for the antibiotic industry". The environmental protection system covers an area of over 300 acres, accounting for over 25% of the total factory area. The total investment in environmental protection facilities is nearly 2.5 billion yuan, accounting for over 30% of the total project investment. It has introduced and integrated key technical equipment such as domestic and foreign advanced molecular sieve/hydrophobic activated carbon, MVR, special membrane, spray drying, etc., which has completely solved the problem of environmental protection "three wastes" treatment, and has reached the advanced level in the treatment capacity of waste water, waste gas, and waste residue. In the field of fermentation tail gas treatment, high-end integrated technologies such as "imported molecular sieve wheels, hydrophobic activated carbon beds, and high-temperature thermal oxidation" have been adopted, ensuring the normal and stable performance of various indicators of the company's fermentation tail gas odor treatment system, with a removal rate of over 95%, and a purification tail gas outlet VOCs of less than 1ppm; In the field of wastewater treatment, multiple technologies such as MVR evaporation and "ultrafiltration+DTNF+DTRO" combined membrane filtration deep treatment are adopted. More than 80% of wastewater is treated and reused for circulating cooling water, pre production process water, and thermoelectric boiler water, achieving the recycling and utilization of wastewater resources and saving primary water resources. The advanced technologies of "DD high-pressure electronic radiation" and "high-temperature hydrolysis+spray drying/disc drying" for antibiotic residue are adopted in the field of residue treatment, so that the antibiotic residue value in the residue is reduced to the undetected level. At the same time, the residue is harmless treated as the raw material for the production of organic fertilizer, realizing the recycling of resources. In January 2018, with the approval of the Ministry of Ecology and Environment, the company established the National Environmental Protection Antibiotic Residue Harmless Treatment and Resource Utilization Engineering Technology Center, and passed the acceptance inspection of Xinjiang Uygur Autonomous Region in January 2020. Chuanning Biotechnology always adheres to the concept of "technological innovation" to drive business development, and takes "R&D innovation" as the core driving force for Chuanning Biotechnology's development. It closely monitors the development of cutting-edge fields such as international biological fermentation and environmental protection treatment. Chuanning Biotechnology has independently innovated and mastered the technologies of strain selection, gene improvement, biological fermentation, extraction, enzymatic hydrolysis, control, and energy conservation and environmental protection in the field of biological fermentation, achieving key breakthroughs in key technologies, links, and fields.We have successively established the "Xinjiang Uygur Autonomous Region Microbial Fermentation Antibiotic Intermediate Engineering Laboratory", "Xinjiang Antibiotic Fermentation Engineering Technology Research Center", and "National Environmental Protection Antibiotic Residue Harmless Treatment and Resource Utilization Engineering Technology Center" with the approval of relevant departments; Rated as the "National Enterprise Technology Center", "Xinjiang Uygur Autonomous Region Enterprise Technology Center", and "Xinjiang Uygur Autonomous Region's Fourth Batch of Circular Economy Pilot Enterprises"; Selected in the "2017 First Batch of Green Manufacturing System Demonstration List" and "List of Intelligent Manufacturing Comprehensive Standardization and New Mode Application Projects of the Ministry of Industry and Information Technology"; Received the title of "2016 National Advanced Collective for Light Industry Science and Technology Innovation during the 12th Five Year Plan" and the "2016 First Prize for Science and Technology Progress in Xinjiang Uygur Autonomous Region". In the future, Chuanning Biology will follow the national western development strategy and the pace of the "the Belt and Road" industrial layout, take advantage of the advantages of natural resources in Xinjiang and the scientific cutting-edge advantages of Shanghai Research Institute, transform from resource factor driven to technological innovation driven, and focus on health care products raw materials, bio pesticides, high value-added natural products, high-end cosmetics raw materials, biodegradable materials and other fields, Develop Chuanning Biotechnology into an innovative synthetic biology enterprise with a global perspective and competitiveness in the field of biological fermentation. |
| Headquarter | Ili Kazakh Autonomous Prefecture |
| Establish Date | 12/10/2010 |
| Listed Code | 301301.SZ |
| Listed Date | 12/27/2022 |
| Chairman | Liu Gexin. |
| CEO | Deng Xuheng. |
| Website | www.klcnsw.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
